These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 7973770)
1. Measuring quality of life: an emerging science. Moinpour CM Semin Oncol; 1994 Oct; 21(5 Suppl 10):48-60; discussion 60-3. PubMed ID: 7973770 [TBL] [Abstract][Full Text] [Related]
2. Quality of life analyses from vinorelbine (Navelbine) clinical trials of women with metastatic breast cancer. Bertsch LA; Donaldson G Semin Oncol; 1995 Apr; 22(2 Suppl 5):45-53; discussion 53-4. PubMed ID: 7740333 [TBL] [Abstract][Full Text] [Related]
3. Vinorelbine (Navelbine)--a new agent for the treatment of non-small cell lung cancer: a summary. Coltman CA Semin Oncol; 1994 Oct; 21(5 Suppl 10):1-3. PubMed ID: 7973763 [TBL] [Abstract][Full Text] [Related]
7. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design. Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of three regimens using vinorelbine (Navelbine) for non-small cell lung cancer. Hillner BE; Smith TJ Semin Oncol; 1996 Apr; 23(2 Suppl 5):25-30. PubMed ID: 8610234 [TBL] [Abstract][Full Text] [Related]
9. Vinorelbine (Navelbine) in the adjuvant and neoadjuvant treatment of non-small cell lung cancer. Viallet J; Ayoub J; Rousseau P; Souhami L; Hohneker J; Shepherd F Semin Oncol; 1994 Oct; 21(5 Suppl 10):64-71; discussion 71-2. PubMed ID: 7973771 [TBL] [Abstract][Full Text] [Related]
10. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer. Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239 [TBL] [Abstract][Full Text] [Related]
11. Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer. Brown J; Thorpe H; Napp V; Fairlamb DJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG; Stephens RJ; Waller D; West P; Peake MD J Clin Oncol; 2005 Oct; 23(30):7417-27. PubMed ID: 16157935 [TBL] [Abstract][Full Text] [Related]
12. Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. Sarna L; Swann S; Langer C; Werner-Wasik M; Nicolaou N; Komaki R; Machtay M; Byhardt R; Wasserman T; Movsas B Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1378-84. PubMed ID: 18501528 [TBL] [Abstract][Full Text] [Related]
13. Oral vinorelbine (Navelbine) in the treatment of advanced non-small cell lung cancer: a preliminary report. Vokes EE; Rosenberg R; Jahanzeb M; Craig J; Gralla R; Belani C; Jones S; Bigley J; Hohneker J Semin Oncol; 1994 Oct; 21(5 Suppl 10):35-8; discussion 38-41. PubMed ID: 7973767 [TBL] [Abstract][Full Text] [Related]
14. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer. Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230 [TBL] [Abstract][Full Text] [Related]
15. Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy. Ozturk A; Sarihan S; Ercan I; Karadag M Am J Clin Oncol; 2009 Feb; 32(1):65-72. PubMed ID: 19194128 [TBL] [Abstract][Full Text] [Related]
16. Pilot study of vinorelbine (navelbine) and paclitaxel in patients with refractory non-small cell lung cancer. Chang AY; DeVore R; Johnson D Semin Oncol; 1996 Apr; 23(2 Suppl 5):19-21. PubMed ID: 8610231 [TBL] [Abstract][Full Text] [Related]
17. Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel. Greimel ER; Bjelic-Radisic V; Pfisterer J; Hilpert F; Daghofer F; du Bois A; J Clin Oncol; 2006 Feb; 24(4):579-86. PubMed ID: 16446330 [TBL] [Abstract][Full Text] [Related]
18. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study. Vokes EE; Haraf DJ; Masters GA; Hoffman PC; Drinkard LC; Ferguson M; Olak J; Watson S; Golomb HM Semin Oncol; 1996 Apr; 23(2 Suppl 5):48-52. PubMed ID: 8610237 [TBL] [Abstract][Full Text] [Related]
19. Vinorelbine (Navelbine) in the treatment of breast cancer: a summary. Abeloff MD Semin Oncol; 1995 Apr; 22(2 Suppl 5):1-4; discussion 41-4. PubMed ID: 7740330 [TBL] [Abstract][Full Text] [Related]
20. [Comparative study on quality of life between weekly and monthly chemotherapy with cisplatin, vindesine and mitomycin C in patients with non-small cell lung cancer]. Ishihara Y; Ichiwata T; Kuramitsu K; Yoneda S; Yamamoto M; Takizawa T; Ogata T; Uchiyama T; Yoshida K Gan To Kagaku Ryoho; 1998 Jun; 25(7):1013-20. PubMed ID: 9644316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]